JPWO2020202072A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020202072A5
JPWO2020202072A5 JP2021560304A JP2021560304A JPWO2020202072A5 JP WO2020202072 A5 JPWO2020202072 A5 JP WO2020202072A5 JP 2021560304 A JP2021560304 A JP 2021560304A JP 2021560304 A JP2021560304 A JP 2021560304A JP WO2020202072 A5 JPWO2020202072 A5 JP WO2020202072A5
Authority
JP
Japan
Prior art keywords
benzoic acid
substituted
dimethylsulfamoyl
unsubstituted
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021560304A
Other languages
English (en)
Japanese (ja)
Other versions
JP7676317B2 (ja
JP2022528271A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/053158 external-priority patent/WO2020202072A1/en
Publication of JP2022528271A publication Critical patent/JP2022528271A/ja
Publication of JPWO2020202072A5 publication Critical patent/JPWO2020202072A5/ja
Application granted granted Critical
Publication of JP7676317B2 publication Critical patent/JP7676317B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021560304A 2019-04-02 2020-04-02 細胞内塩素イオン濃度のモジュレーター Active JP7676317B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102019000004929 2019-04-02
IT201900004929 2019-04-02
PCT/IB2020/053158 WO2020202072A1 (en) 2019-04-02 2020-04-02 Modulators of intracellular chloride concentration

Publications (3)

Publication Number Publication Date
JP2022528271A JP2022528271A (ja) 2022-06-09
JPWO2020202072A5 true JPWO2020202072A5 (enExample) 2023-04-10
JP7676317B2 JP7676317B2 (ja) 2025-05-14

Family

ID=67185615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021560304A Active JP7676317B2 (ja) 2019-04-02 2020-04-02 細胞内塩素イオン濃度のモジュレーター

Country Status (10)

Country Link
US (1) US20220184008A1 (enExample)
EP (1) EP3947345A1 (enExample)
JP (1) JP7676317B2 (enExample)
KR (1) KR20220022051A (enExample)
CN (2) CN120661491A (enExample)
AU (1) AU2020251023B2 (enExample)
CA (1) CA3135339A1 (enExample)
IL (1) IL286900B2 (enExample)
SG (1) SG11202110950XA (enExample)
WO (1) WO2020202072A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202300007521A1 (it) 2023-04-18 2024-10-18 Iama Therapeutics S R L Processo per la preparazione di derivati dell'acido sulfamoilbenzoico
WO2025257786A1 (en) * 2024-06-13 2025-12-18 Iama Therapeutics S.R.L. Benzoimidazole derivatives as nkcc1 inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493584A (en) * 1966-02-21 1970-02-03 Smithkline Corp 4-substituted amino-5-sulfamoylbenzoic acid derivatives and preparation
DE2412884A1 (de) * 1974-03-18 1975-10-16 Hoechst Ag Basisch substituierte benzolsulfonamide und verfahren zu ihrer herstellung
DE2442851A1 (de) * 1974-09-06 1976-03-18 Hoechst Ag Basisch substituierte 3-sulfamoylbenzoesaeurederivate und verfahren zu ihrer herstellung
DE2517183A1 (de) * 1975-04-18 1976-10-28 Hoechst Ag Basisch substituierte 5-sulfamoyl- anthranilsaeurederivate und verfahren zu ihrer herstellung
DE3101960A1 (de) * 1981-01-22 1982-09-02 Hoechst Ag, 6000 Frankfurt "basisch substituierte anthranilsaeuren, verfahren zu ihrer herstellung und ihre verwendung"
BE1012386A3 (fr) * 1999-01-15 2000-10-03 Univ Liege Derives de sulfonamides benzeniques et leurs utilisations.
WO2000058277A1 (en) 1999-03-31 2000-10-05 American Home Products Corporation Aryl sulfonic acids and derivatives as fsh antagonists
US6355633B1 (en) * 1999-03-31 2002-03-12 American Home Products Corporation Aryl sulfonic acids and derivatives as FSH antagonists
AU2001234180A1 (en) * 2000-02-25 2001-09-03 Japan Tobacco Inc. Benzamide derivative and use thereof
JP2002201172A (ja) * 2000-02-25 2002-07-16 Japan Tobacco Inc ベンズアミド誘導体及びその用途
US7544676B2 (en) * 2005-11-10 2009-06-09 Adolor Corporation Sulfamoyl benzamides and methods of their use
US7462611B2 (en) 2006-06-22 2008-12-09 Anadys Pharmaceuticals, Inc. Pyrro[1,2-b]pyridazinone compounds
US7906555B2 (en) 2006-10-26 2011-03-15 Arizona Board Of Regents On Behalf Of The University Of Arizona Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
MX2011007759A (es) * 2009-01-22 2011-10-11 Neurotherapeutics Pharma Inc Analogos de bumetanida, furosemida, piretanida, azosemida y torsemida, composiciones y metodos de uso.
JP2011231094A (ja) 2009-11-02 2011-11-17 Neurotherapeutics Pharma Inc ブメタニド、フロセミド、ピレタニド、アゾセミド、およびトルセミドのアナログ、組成物および使用方法

Similar Documents

Publication Publication Date Title
RU2368604C2 (ru) Ингибиторы фосфодиэстеразы 4, включающие n-замещенные аналоги анилина и дифениламина
JP2011526594A5 (enExample)
JP2006022108A5 (enExample)
JP2005506308A5 (enExample)
JP2008516986A5 (enExample)
JP2005522438A5 (enExample)
SI2961736T1 (en) Histone demethylase inhibitors
JP2001526223A (ja) 置換複素環尿素を用いるｐ３８キナーゼの阻害
JP2014530900A5 (enExample)
CA2435067A1 (en) Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
JP2011529037A5 (enExample)
JP2009519340A5 (enExample)
JP2010522197A5 (enExample)
RU2005121897A (ru) Производные аминоиндазолов и их применение в качестве ингибиторов киназ
BRPI0507506A (pt) compostos
JP2006504656A5 (enExample)
JP2006077019A5 (enExample)
RU2007119427A (ru) Соединения, являющиеся ингибиторами гликогенфосфорилазы, и фармацевтические композиции на их основе
RU2006101541A (ru) Производные пиперазина и способ их применения
JP2004502670A5 (enExample)
JP2006507329A5 (enExample)
RU2015101210A (ru) Производные тиофена, используемые для лечения сахарного диабета
JP2017507915A5 (enExample)
RU2008107733A (ru) Ингибиторы gsk-3
HRP20150049T1 (hr) Derivati oksazolil-metiletera kao agonisti alx-receptora